• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084

Introduction to 6-(5-Fluoro-2-hydroxyphenyl)-2-formylphenol (CAS No. 1261902-59-3)

6-(5-Fluoro-2-hydroxyphenyl)-2-formylphenol, identified by its CAS number 1261902-59-3, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical research and development. This compound belongs to a class of molecules that exhibit promising biological activities, making it a valuable candidate for further exploration in drug discovery and medicinal chemistry.

The structure of 6-(5-Fluoro-2-hydroxyphenyl)-2-formylphenol consists of a phenolic core substituted with a formyl group at the 2-position and a fluoro-substituted hydroxyphenyl group at the 5-position. This unique arrangement of functional groups contributes to its distinctive chemical properties and potential biological interactions. The presence of both hydroxyl and formyl groups makes it a versatile intermediate in synthetic chemistry, enabling the modification and derivatization of the molecule for various applications.

In recent years, there has been a growing interest in developing novel therapeutic agents that target complex diseases such as cancer, inflammation, and neurodegenerative disorders. The< strong>6-(5-Fluoro-2-hydroxyphenyl)-2-formylphenol molecule has shown potential in several preclinical studies due to its ability to interact with specific biological targets. For instance, its structure resembles that of known pharmacophores found in active pharmaceutical ingredients (APIs), suggesting that it may have similar or enhanced biological activities.

One of the most compelling aspects of 6-(5-Fluoro-2-hydroxyphenyl)-2-formylphenol is its potential as a scaffold for drug design. The formyl group can participate in various chemical reactions, such as condensation with amines to form amides or Schiff bases, while the hydroxyl and fluoro substituents can be further functionalized to improve solubility, bioavailability, and metabolic stability. These properties make it an attractive candidate for medicinal chemists looking to develop next-generation drugs.

The< strong>CAS number 1261902-59-3 provides a unique identifier for this compound, ensuring accurate documentation and traceability in research and industrial settings. This standardized classification system is essential for regulatory compliance and facilitates efficient communication among scientists working on related projects.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to predict the binding affinity and mechanism of action of 6-(5-Fluoro-2-hydroxyphenyl)-2-formylphenol with high precision. These computational studies have revealed that the molecule may interact with enzymes and receptors involved in disease pathways, providing a rational basis for further experimental validation.

In addition to its pharmaceutical applications, 6-(5-Fluoro-2-hydroxyphenyl)-2-formylphenol has potential uses in other areas such as agrochemicals and material science. Its unique chemical structure allows for the development of novel compounds with tailored properties, which could be beneficial in crop protection or advanced material formulations.

The synthesis of< strong>6-(5-Fluoro-2-hydroxyphenyl)-2-formylphenol presents both challenges and opportunities for organic chemists. While there are established synthetic routes to similar compounds, optimizing the yield and purity of this specific molecule requires careful consideration of reaction conditions and purification techniques. Researchers have explored various methodologies, including palladium-catalyzed cross-coupling reactions and selective oxidation processes, to achieve high-quality samples for further study.

The< strong>CAS number 1261902-59-3 serves as a critical reference point for all researchers working with this compound. It ensures that all documentation, including patents, scientific papers, and regulatory submissions, is consistent and unambiguous. This level of precision is essential for collaborative research projects involving multiple institutions or companies.

The biological activity of< strong>6-(5-Fluoro-2-hydroxyphenyl)-2-formylphenol has been explored in several preclinical models. Initial studies suggest that it may possess anti-inflammatory, antioxidant, or anticancer properties depending on the specific derivatives synthesized. These findings are particularly exciting given the growing demand for targeted therapies that address unmet medical needs.

The development of novel drug candidates is a complex process that involves multiple stages from discovery to clinical trials. The< strong>CAS number 1261902-59-3 plays a crucial role in this process by providing a standardized identifier that ensures seamless transition between different phases of drug development. This continuity is vital for maintaining data integrity and regulatory compliance throughout the pipeline.

The future prospects for< strong>6-(5-Fluoro-2-hydroxyphenyl)-2-formylphenol are bright, with ongoing research aimed at expanding its therapeutic applications. Collaborative efforts between academic institutions, biotechnology companies, and pharmaceutical firms are likely to yield innovative derivatives with enhanced efficacy and safety profiles. As our understanding of disease mechanisms continues to evolve, compounds like this one will remain at the forefront of drug discovery efforts.

• 1111120-19-4(5-(5-fluoro-2-hydroxyphenyl)-2-hydroxybenzaldehyde)
• 1261890-24-7(6-(2,5-Difluorophenyl)-2-formylphenol)
• 847754-82-9(5-(4-fluorophenyl)-2-hydroxybenzaldehyde)
• 1111129-25-9(5-(3,4-difluorophenyl)-2-hydroxybenzaldehyde)
• 1098984-26-9(5-(3-fluoro-4-hydroxyphenyl)-2-hydroxybenzaldehyde)
• 343603-87-2(3-(4-fluorophenyl)-2-hydroxybenzaldehyde)
• 1111129-22-6(5-(5-fluoro-2-methylphenyl)-2-hydroxybenzaldehyde)
• 1111129-11-3(5-(3,5-difluorophenyl)-2-hydroxybenzaldehyde)
• 1258634-92-2(6-(3-Fluorophenyl)-2-formylphenol)
• 1111129-26-0(4-(3-Fluoro-4-methylphenyl)-2-formylphenol)